Skip navigation
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Oncology meetings & conferences

30 meetings & conferences listed in Oncology 

25th Annual Interdisciplinary Breast Center Conference
United States

25th Annual Interdisciplinary Breast Center Conference

March 14-18, 2015 Las Vegas, Nevada

At each year’s conference, the NCBC brings together medical and industry professionals from around the globe to network, learn and share ideas, methodologies and treatment options that improve quality of care and outcome for patients diagnosed with breast diseases.

The NCBC is dedicated to providing opportunities for continuing education to oncologists, surgeons, nurses, clinicians and administrators in order to help in advancing the delivery of treatment options and quality of care.

Nurse, Nurse Researcher, Oncologist, Physician, Physician Researcher, Surgeon
VI InterAmerican Oncology Conference: Current Status and Future of Anti-Cancer Targeted Therapies

VI InterAmerican Oncology Conference: Current Status and Future of Anti-Cancer Targeted Therapies

October 8th and 9th, 2015 Buenos Aires, Argentina

The 6th conference “Current Status and Future of Anti-Cancer Targeted Therapies” will be held in Buenos Aires, Argentina on October 8th. and 9th, 2015.

An outstanding faculty of speakers from the United States and Europe has committed to participate in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types.

The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies, and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development.  

This meeting is the primary opportunity for practicing oncologists, hematologists, basic and clinical, translational investigators, scientists  and cancer related health care workers oncologists and health workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care. 

The meeting does not charge a registration fee and the presentations are translated into Spanish in real time for the attendees.

Hematologist, Oncologist, Physician, Physician Researcher
15th International Myeloma Workshop

15th International 15th International Myeloma Workshop

September 23rd to 26th, 2015 Rome, Italy

The 15th International Myeloma Workshop will be held in Rome, Italy, from September 23rd to 26th, 2015.

During this important biannual event, the emerging advances in the biology and treatment of multiple myeloma, as well as debates on more controversial arguments, and consensus report will be presented.


September 23rd to 26th, 2015 Rome, Italy

The 15th International Myeloma Workshop will be held in Rome, Italy, from September 23rd to 26th, 2015.

During this important biannual event, the emerging advances in the biology and treatment of multiple myeloma, as well as debates on more controversial arguments, and consensus report will be presented.

Hematologist, Oncologist, Physician, Physician Researcher
World Congress on Controversies in Breast Cancer

World Congress on Controversies in Breast Cancer

October 22-25, 2015 Melbourne, Australia

Congresses are numerous, but few address the key issues facing clinicians in their daily practice. New information is often presented, but rarely in a form that is ready for use and the gap between theory and practice is not always addressed. The CoBRA congress will be different. It will deal with controversial issues in aspects of breast cancer care, with presentations, debates and discussions. The congress will provide a forum for key opinion leaders to effectively debate unresolved clinical and therapeutic dilemmas.

Oncologist, Physician, Physician Researcher
4th International Conference on Computational & Mathematical Biomedical Engineering

4th International Conference on Computational & Mathematical Biomedical Engineering

29 June - 1 July 2015

Ecole Normale Superieure de Cahan (ENS Cachan) 61 Avenue du President Wilson 94230 Cachan, France

Computational and Mathematical Biomedical Engineering is a rapidly expanding research area with the promise of considerable implications on human health and wellbeing. Computational and mathematical modelling now plays a significant role in improving our knowledge of the biological processes in the human body and the pathophysiology of diseases. In addition, it supports the development of appropriate diagnostic tools, new instrumentation and medical devices to enable better clinical outcomes.

The International Conference on Computational & Mathematical Biomedical Engineering aims at bringing together fellow researchers and academics, specialists of several disciplines, practitioners and graduate students with a common interest, to discuss the current state of the art of Computational Biomedical Engineering research.


• Cardiovascular problems

• Respiratory systems

• Biofluid Mechanics

• Soft tissue, constitutive modelling

• Experimental validation

• Numerical methods

• Multiscale modelling

• Analytical approaches

• High performance computing

• Biological heat and mass transfer

• Biology and its links to diseases

• Biomechanics and Oncology

• Clinical relevance

• Imaging and image processing

• Uncertainty quantification

• Biomedical devices

Biologist, Biomedical Engineer, Computer Scientist, Physician Researcher, Technologist
Association of Oncology Social Work 31st Annual Conference
United States

Association of Oncology Social Work 31st Annual Conference

“Leading With Skill and Passion: Oncology Social Workers at the Forefront of Cancer Care”

May 20-22, 2015 Seattle, Washington

The AOSW Annual Conference is a unique opportunity for oncology social workers, their colleagues and companies that support patients and healthcare providers to gather information, share knowledge, support and guide each other.

Each year, AOSW Annual Conference Committee members organize the annual conference around presentations and educational sessions that reflect the most current issues facing adult oncology social workers, while also embracing and incorporating lessons previously shared. In this way AOSW honors its past as it prepares to meet future challenges and opportunities that are not only welcomed but actively sought.

The AOSW 31st Annual Conference in 2015 will be held in Seattle, Washington, USA. Known for its spirit of optimism, Seattle is an ideal backdrop for the AOSW conference. Like AOSW, Seattle places a priority on continuing to expand and grow its diverse communities.

Social Worker
2015 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer
United States

2015 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer

March 28-31, 2015 Chicago, Illinois

Since 1969, women’s health care professionals have convened at the Society of Gynecologic Oncology (SGO)’s Annual Meeting on Women’s Cancer to discuss the latest science in the field, receive educational programming, and to network. Now in its 46th year, the SGO Annual Meeting continues to be the premier educational and scientific event for those who treat and care for women with gynecologic cancer.

Members of the entire gynecologic cancer care team who provide treatment and care in the areas of chemotherapy, radiation therapy, surgery, and palliative care attend the SGO Annual Meeting. Gynecologic oncologists make up a large population of the attendees, along with medical oncologists, pathologists, radiation oncologists, hematologists, surgical oncologists, obstetrician/gynecologists, nurses, physician assistants, fellows in training, residents, and social workers.

The SGO Annual Meeting also brings together exhibitors from a variety of medical device and service companies. An array of state-of-the-art products and services geared towards members of the gynecologic cancer care team are on display in the exhibition area.

Hematologist, Medical Resident, Nurse, Oncologist, Pathologist, Physician Researcher, Postdoctoral Fellow, Radiation Oncologist, Social Worker
EMBL Conference: Cancer Genomics

EMBL Conference: Cancer Genomics

Sunday 1 November - Wednesday 4 November 2015 European Molecular Biology Laboratory Heidelberg, Germany

• Topics

◦ Cancer Genetics

◦ Functional Genomics & Epigenomics of Cancer

◦ Systems Biology & Integrated Analyses of Cancer

◦ Cancer Model Systems & Systems Pharmacology

◦ Translation & Clinical Impact of Cancer Genomics

This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models, and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium ( projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2013 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions, and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.

Biologist, Geneticist , Molecular Biologist, Oncologist, Pharmacologist, Physician Researcher
2015 Controlling Cancer Summit
United Kingdom

2015 Controlling Cancer Summit

Tuesday, 12 May 2015 09:00 - Thursday, 14 May 2015 17:00 London, United Kingdom

With plenty of opportunity  for networking and debate, this informal international  meeting will bring you up to date with current research and thinking regarding cancer screening, prevention and treatment.  Presenters will include Clinicians, Academics and members of the Pharmaceutical industry.

Who Should Attend

The conference is open to academics, clinicians and industrial partners creating a stimulating environment in which to promote lively discussion, productive collaboration and innovation.

Academic, Oncologist, Pharmacologist, Physician, Physician Researcher
MicroRNAs and Noncoding RNAs in Cancer
United States

MicroRNAs and Noncoding RNAs in Cancer

June 7—12, 2015 Keystone, Colorado

MicroRNAs and other noncoding RNAs have recently emerged as key regulators of gene expression during development and are frequently mis-expressed in human disease states, in particular cancer. MicroRNAs act to promote or repress cell proliferation, migration and apoptosis during development, all processes that go awry in cancer. Thus, microRNAs have the ability to behave like oncogenes or tumor suppressors. Their small size and molecular properties make microRNAs amenable as targets and therapeutics in cancer treatment. MicroRNAs thus present a paradigm shift in thinking about gene regulation during development and disease and provide the oncologist with a potentially powerful new battery of agents to diagnose and treat cancer. However, while hundreds of human microRNAs and noncoding RNAs are known, relatively little is known about their roles and targets, and there is still a limited literature on using these molecules in the clinic. The specific aims of this meeting serve to address these deficiencies and are as follows: 1) Focus on the exciting biology of microRNAs and noncoding RNAs in controlling developmental and cancer processes like cell proliferation, differentiation, cell cycle, apoptosis and metastasis. This meeting will highlight the best current research into the role that miRNAs play in these fundamental processes and provide the basic understanding that will drive the invention of powerful clinical tools; 2) Focus on the latest efforts to harness the power of these RNAs as agents in the fight against cancer. Discussions will range from use of miRNAs as diagnostic and prognostic markers in cancer, to SNPs providing risk factors for cancer, to the delivery and effectiveness of small RNA therapeutics in clinically relevant settings; 3) Attract the best researchers working in small RNAs and cancer to one place for critical discussions that will advance the field and accelerate the benchside to bedside use of this technology; and 4) Provide a stimulating environment where students, postdocs and junior investigators can present and discuss their research with the best minds in the field.

Cell Biologist, Graduate Student, Junior Investigator, Junior Researcher, Junior Scientist, Molecular Biologist, Oncologist, Physician Researcher, Postdoctoral Fellow